HIV positive patient treated with ixekizumab
Vol. 173 No. 3 (2022), Case report
Vol. 173 No. 3 (2022)

HIV positive patient treated with ixekizumab: doi: 10.7417/CT.2022.2416

Case report
Published 2022-05-26
N. Bernardini
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
N. Skroza
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
E. Tolino
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
A. Marchesiello
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
A. Mambrin
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
V. Balduzzi
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
S. Michelini
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
P. Maddalena
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
S. Volpe
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
I. Proietti
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy
C. Potenza
Dermatology Unit “D. Innocenzi”, Polo Pontino, Sapienza University of Rome, Rome, Italy

Abstract

Psoriasis is a immune-mediated, chronic, inflammatory skin disease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic management of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.

PDF (Italiano)